| Post kala-azar dermal leishmaniasis: A threat to elimination program MR Gedda, B Singh, D Kumar, AK Singh, P Madhukar, S Upadhyay, ... PLoS Neglected Tropical Diseases 14 (7), e0008221, 2020 | 61 | 2020 |
| Epigenetic aspects of engineered nanomaterials: is the collateral damage inevitable? MR Gedda, PK Babele, K Zahra, P Madhukar Frontiers in Bioengineering and Biotechnology 7, 228, 2019 | 55 | 2019 |
| Evaluation of Safety and Antileishmanial Efficacy of Amine Functionalized Carbon-Based Composite Nanoparticle Appended With Amphotericin B: An in vitro and … MR Gedda, P Madhukar, AK Vishwakarma, V Verma, AK Kushwaha, ... Frontiers in chemistry 8, 510, 2020 | 34 | 2020 |
| Nanodiagnostics in leishmaniasis: A new frontiers for early elimination MR Gedda, P Madhukar, A Shukla, SL Mudavath, ON Srivastava, ... Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 13 (2 …, 2021 | 31 | 2021 |
| Ethyl Acetate Extract of Colletotrichum gloeosporioides Promotes Cytotoxicity and Apoptosis in Human Breast Cancer Cells N Rai, P Gupta, A Verma, RK Tiwari, P Madhukar, SC Kamble, A Kumar, ... ACS omega 8 (4), 3768-3784, 2023 | 26 | 2023 |
| Post kala-azar dermal leishmaniasis in the Indian sub-continent: Challenges and strategies for elimination A Kumar, VK Singh, R Tiwari, P Madhukar, Rajneesh, S Kumar, V Gautam, ... Frontiers in Immunology 14, 1236952, 2023 | 14 | 2023 |
| Nanotechnology-based strategies in parasitic disease management: from prevention to diagnosis and treatment R Tiwari, RP Gupta, VK Singh, A Kumar, Rajneesh, P Madhukar, ... ACS omega 8 (45), 42014-42027, 2023 | 11 | 2023 |
| Blood biomarkers for ischemic stroke subtype differentiation: A systematic review SP Pandey, P Madhukar, P Dev, D Joshi, VN Mishra, RN Chaurasia, ... Cardiovascular Hematological Disorders Drug Targets 19 (3), 215-227, 2019 | 6 | 2019 |
| Blood biomarkers for the differentiation of cardiac ischemic stroke subtypes: a systematic review A Pathak, SP Pandey, P Madhukar, P Dev, D Joshi, VN Mishra, ... Cardiovascular & Haematological Disorders-Drug Targetsrug Targets …, 2019 | 4 | 2019 |
| Evaluation of blood based quantitative PCR as a molecular diagnostic tool for post kala-azar dermal leishmaniasis (PKDL) A Kumar, VK Singh, P Madhukar, R Tiwari, R Roy, Rajneesh, S Mehrotra, ... Molecular Biology Reports 51 (1), 716, 2024 | 1 | 2024 |
| Dual Drug delivery for augmenting bacterial wound complications via tailored ultradeformable carriers K Arora, B Dhruw, S Pm, P Madhukar, S Sundar, SL Mudavath Bioconjugate Chemistry 35 (6), 766-779, 2024 | 1 | 2024 |
| Post-Stroke Treatment Strategies, Management, and Rehabilitation: Where We Stand? MR Gedda, SP Pandey, K Zahra, P Madhukar, A Pathak Advancement in the Pathophysiology of Cerebral Stroke, 177-189, 2019 | 1 | 2019 |
| Anti-leishmanial therapies: overcoming current challenges with emerging therapies S Sundar, P Madhukar, R Kumar Expert Review of Anti-infective Therapy, 2025 | | 2025 |
| Nanomedicine in Cardiovascular Diseases: Diagnostic and Therapeutic Innovations for Better Health P Madhukar, VK Singh, SB Chauhan, R Tiwari, A Kumar, R Kumar Nanomedicine, 233-246, 2024 | | 2024 |
| MicroRNAs-mediated regulation of immune responses in parasitic infection R Roy, P Madhukar, VK Singh, R Tiwari, A Kumar, M Rai, V Gautam, ... MicroRNA in Human Infectious Diseases, 239-263, 2024 | | 2024 |
| Generation and validation of Streptozotocin induced mouse model of sporadic Alzheimer’s disease S Prasad, P Madhukar | | |
Mallikarjuna R GeddaNational Institutes of HealthE-mail megerősítve itt: nih.gov